RHB Retail Research
Technical Analysis - CCM Duopharma Biotech
_20180626173557.jpg)
CCM Duopharma Biotech was testing the MYR1.47 level in its latest session. A bullish bias may be present above this point with a target price of MYR1.60, followed by MYR1.70. The stock may take a breather if it cannot breach the MYR1.47 mark in the coming sessions. Support may be found at MYR1.33, where traders can exit upon a breach to limit the downside risk.
Source: RHB Securities Research - 21 Jun 2018
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
.png)
Apps
Top Articles
1
AmInvest Research Reports
2
3
Rockstone Investment
Binastra Corp Bhd – A Promising Investment in Construction in 2025
4
save malaysia!
5
8
CEO Morning Brief
China Probes Calvin Klein Parent Over Suspected Xinjiang Boycott
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
